Which closed-end funds own Bridgebio Pharma Inc?
1 active closed-end fund report this security in their latest N-PORT filing, with a combined reported value of $6.5K. Security type: debt security. Country: United States. CUSIP 10806XAB8 · ISIN US10806XAB82.
Holdings are historical filings (report dates May 29, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| VGI Virtus Global Multi-Sector Income Fund | Multi-Asset | 0.01% | $6.5K | 4,000 par | $129M | 10.6% discount | May 29, 2026 |
1 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Bridgebio Pharma Inc | common equity | 8 |
| Bridgebio Pharma Inc | debt security | 7 |
| Bridgebio Pharma Inc | debt security | 6 |
| Bridgebio Pharma Inc | debt security | 4 |
Issuer-level search for “BRIDGEBIO PHARMA INC” → · Compare two funds’ portfolios →